Predicting resectability after neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer: a single center, retrospective trial.

Front Oncol · 2025 · PMC12490984 · PMID 41049856

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

approaches statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

This result approaches statistical significance (p = 0.06).

also in 141 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.